カテゴリー： Market Monitor Global, 世界, 医療/バイオ

A型肝炎＆B型肝炎予防接種の世界市場見通し2023年-2029年

◆英語タイトル：Hepatitis A and B Vaccination Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5612）

◆商品コード：MMG23JU5612
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：117
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Hepatitis A and B Vaccination Market 調査レポートは次の情報を含め、グローバルにおけるのA型肝炎＆B型肝炎予防接種市場規模と予測を収録しています。・世界のA型肝炎＆B型肝炎予防接種市場：売上、2018年-2023年、2024年-2029年
・世界のA型肝炎＆B型肝炎予防接種市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のA型肝炎＆B型肝炎予防接種市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「A型肝炎ワクチン」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

A型肝炎＆B型肝炎予防接種のグローバル主要企業は、GSK、 Merck、 Sanofi、 Sinovac、 Zhejiang Pukang、 Changchun Institute of Biological、 KM Biologics、 IMBCAMS、 Convac、 NCPC、 Bio Kangtai、 Dynavax、 Hissen、 LG Life Sciences、 Serum Instituteなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、A型肝炎＆B型肝炎予防接種のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のA型肝炎＆B型肝炎予防接種市場：タイプ別、2018年-2023年、2024年-2029年
世界のA型肝炎＆B型肝炎予防接種市場：タイプ別市場シェア、2022年
・A型肝炎ワクチン、B型肝炎ワクチン

世界のA型肝炎＆B型肝炎予防接種市場：用途別、2018年-2023年、2024年-2029年
世界のA型肝炎＆B型肝炎予防接種市場：用途別市場シェア、2022年
・政府機関、民間、その他

世界のA型肝炎＆B型肝炎予防接種市場：地域・国別、2018年-2023年、2024年-2029年
世界のA型肝炎＆B型肝炎予防接種市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるA型肝炎＆B型肝炎予防接種のグローバル売上、2018年-2023年
・主要企業におけるA型肝炎＆B型肝炎予防接種のグローバル売上シェア、2022年
・主要企業におけるA型肝炎＆B型肝炎予防接種のグローバル販売量、2018年-2023年
・主要企業におけるA型肝炎＆B型肝炎予防接種のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
GSK、 Merck、 Sanofi、 Sinovac、 Zhejiang Pukang、 Changchun Institute of Biological、 KM Biologics、 IMBCAMS、 Convac、 NCPC、 Bio Kangtai、 Dynavax、 Hissen、 LG Life Sciences、 Serum Institute

*************************************************************

・調査・分析レポートの概要
A型肝炎＆B型肝炎予防接種市場の定義
市場セグメント
世界のA型肝炎＆B型肝炎予防接種市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のA型肝炎＆B型肝炎予防接種市場規模
世界のA型肝炎＆B型肝炎予防接種市場規模：2022年 VS 2029年
世界のA型肝炎＆B型肝炎予防接種市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのA型肝炎＆B型肝炎予防接種の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のA型肝炎＆B型肝炎予防接種製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：A型肝炎ワクチン、B型肝炎ワクチン
A型肝炎＆B型肝炎予防接種のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：政府機関、民間、その他
A型肝炎＆B型肝炎予防接種の用途別グローバル売上・予測

・地域別市場分析
地域別A型肝炎＆B型肝炎予防接種市場規模 2022年と2029年
地域別A型肝炎＆B型肝炎予防接種売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
GSK、 Merck、 Sanofi、 Sinovac、 Zhejiang Pukang、 Changchun Institute of Biological、 KM Biologics、 IMBCAMS、 Convac、 NCPC、 Bio Kangtai、 Dynavax、 Hissen、 LG Life Sciences、 Serum Institute
...

The hepatitis A and hepatitis B vaccines can be given separately or as a combination vaccine. All the shots in the series are needed for long-term protection. The full series of the hepatitis A and hepatitis B vaccines require 2-3 shots, depending on the type of vaccine.
This report aims to provide a comprehensive presentation of the global market for Hepatitis A and B Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis A and B Vaccination. This report contains market size and forecasts of Hepatitis A and B Vaccination in global, including the following market information:
Global Hepatitis A and B Vaccination Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hepatitis A and B Vaccination Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Hepatitis A and B Vaccination companies in 2022 (%)
The global Hepatitis A and B Vaccination market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Hepatitis A Vaccination Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hepatitis A and B Vaccination include GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS and Convac, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hepatitis A and B Vaccination manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis A and B Vaccination Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Hepatitis A and B Vaccination Market Segment Percentages, by Type, 2022 (%)
Hepatitis A Vaccination
Hepatitis B Vaccination
Global Hepatitis A and B Vaccination Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Hepatitis A and B Vaccination Market Segment Percentages, by Application, 2022 (%)
Government Institution
Private Sector
Other
Global Hepatitis A and B Vaccination Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Hepatitis A and B Vaccination Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis A and B Vaccination revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hepatitis A and B Vaccination revenues share in global market, 2022 (%)
Key companies Hepatitis A and B Vaccination sales in global market, 2018-2023 (Estimated), (Units)
Key companies Hepatitis A and B Vaccination sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
NCPC
Bio Kangtai
Dynavax
Hissen
LG Life Sciences
Serum Institute
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hepatitis A and B Vaccination, market overview.
Chapter 2: Global Hepatitis A and B Vaccination market size in revenue and volume.
Chapter 3: Detailed analysis of Hepatitis A and B Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hepatitis A and B Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hepatitis A and B Vaccination capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Hepatitis A and B Vaccination Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis A and B Vaccination Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis A and B Vaccination Overall Market Size
2.1 Global Hepatitis A and B Vaccination Market Size: 2022 VS 2029
2.2 Global Hepatitis A and B Vaccination Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Hepatitis A and B Vaccination Sales: 2018-2029
3 Company Landscape
3.1 Top Hepatitis A and B Vaccination Players in Global Market
3.2 Top Global Hepatitis A and B Vaccination Companies Ranked by Revenue
3.3 Global Hepatitis A and B Vaccination Revenue by Companies
3.4 Global Hepatitis A and B Vaccination Sales by Companies
3.5 Global Hepatitis A and B Vaccination Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hepatitis A and B Vaccination Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hepatitis A and B Vaccination Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatitis A and B Vaccination Players in Global Market
3.8.1 List of Global Tier 1 Hepatitis A and B Vaccination Companies
3.8.2 List of Global Tier 2 and Tier 3 Hepatitis A and B Vaccination Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Hepatitis A and B Vaccination Market Size Markets, 2022 & 2029
4.1.2 Hepatitis A Vaccination
4.1.3 Hepatitis B Vaccination
4.2 By Type – Global Hepatitis A and B Vaccination Revenue & Forecasts
4.2.1 By Type – Global Hepatitis A and B Vaccination Revenue, 2018-2023
4.2.2 By Type – Global Hepatitis A and B Vaccination Revenue, 2024-2029
4.2.3 By Type – Global Hepatitis A and B Vaccination Revenue Market Share, 2018-2029
4.3 By Type – Global Hepatitis A and B Vaccination Sales & Forecasts
4.3.1 By Type – Global Hepatitis A and B Vaccination Sales, 2018-2023
4.3.2 By Type – Global Hepatitis A and B Vaccination Sales, 2024-2029
4.3.3 By Type – Global Hepatitis A and B Vaccination Sales Market Share, 2018-2029
4.4 By Type – Global Hepatitis A and B Vaccination Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Hepatitis A and B Vaccination Market Size, 2022 & 2029
5.1.2 Government Institution
5.1.3 Private Sector
5.1.4 Other
5.2 By Application – Global Hepatitis A and B Vaccination Revenue & Forecasts
5.2.1 By Application – Global Hepatitis A and B Vaccination Revenue, 2018-2023
5.2.2 By Application – Global Hepatitis A and B Vaccination Revenue, 2024-2029
5.2.3 By Application – Global Hepatitis A and B Vaccination Revenue Market Share, 2018-2029
5.3 By Application – Global Hepatitis A and B Vaccination Sales & Forecasts
5.3.1 By Application – Global Hepatitis A and B Vaccination Sales, 2018-2023
5.3.2 By Application – Global Hepatitis A and B Vaccination Sales, 2024-2029
5.3.3 By Application – Global Hepatitis A and B Vaccination Sales Market Share, 2018-2029
5.4 By Application – Global Hepatitis A and B Vaccination Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Hepatitis A and B Vaccination Market Size, 2022 & 2029
6.2 By Region – Global Hepatitis A and B Vaccination Revenue & Forecasts
6.2.1 By Region – Global Hepatitis A and B Vaccination Revenue, 2018-2023
6.2.2 By Region – Global Hepatitis A and B Vaccination Revenue, 2024-2029
6.2.3 By Region – Global Hepatitis A and B Vaccination Revenue Market Share, 2018-2029
6.3 By Region – Global Hepatitis A and B Vaccination Sales & Forecasts
6.3.1 By Region – Global Hepatitis A and B Vaccination Sales, 2018-2023
6.3.2 By Region – Global Hepatitis A and B Vaccination Sales, 2024-2029
6.3.3 By Region – Global Hepatitis A and B Vaccination Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Hepatitis A and B Vaccination Revenue, 2018-2029
6.4.2 By Country – North America Hepatitis A and B Vaccination Sales, 2018-2029
6.4.3 US Hepatitis A and B Vaccination Market Size, 2018-2029
6.4.4 Canada Hepatitis A and B Vaccination Market Size, 2018-2029
6.4.5 Mexico Hepatitis A and B Vaccination Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Hepatitis A and B Vaccination Revenue, 2018-2029
6.5.2 By Country – Europe Hepatitis A and B Vaccination Sales, 2018-2029
6.5.3 Germany Hepatitis A and B Vaccination Market Size, 2018-2029
6.5.4 France Hepatitis A and B Vaccination Market Size, 2018-2029
6.5.5 U.K. Hepatitis A and B Vaccination Market Size, 2018-2029
6.5.6 Italy Hepatitis A and B Vaccination Market Size, 2018-2029
6.5.7 Russia Hepatitis A and B Vaccination Market Size, 2018-2029
6.5.8 Nordic Countries Hepatitis A and B Vaccination Market Size, 2018-2029
6.5.9 Benelux Hepatitis A and B Vaccination Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Hepatitis A and B Vaccination Revenue, 2018-2029
6.6.2 By Region – Asia Hepatitis A and B Vaccination Sales, 2018-2029
6.6.3 China Hepatitis A and B Vaccination Market Size, 2018-2029
6.6.4 Japan Hepatitis A and B Vaccination Market Size, 2018-2029
6.6.5 South Korea Hepatitis A and B Vaccination Market Size, 2018-2029
6.6.6 Southeast Asia Hepatitis A and B Vaccination Market Size, 2018-2029
6.6.7 India Hepatitis A and B Vaccination Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Hepatitis A and B Vaccination Revenue, 2018-2029
6.7.2 By Country – South America Hepatitis A and B Vaccination Sales, 2018-2029
6.7.3 Brazil Hepatitis A and B Vaccination Market Size, 2018-2029
6.7.4 Argentina Hepatitis A and B Vaccination Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Hepatitis A and B Vaccination Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Hepatitis A and B Vaccination Sales, 2018-2029
6.8.3 Turkey Hepatitis A and B Vaccination Market Size, 2018-2029
6.8.4 Israel Hepatitis A and B Vaccination Market Size, 2018-2029
6.8.5 Saudi Arabia Hepatitis A and B Vaccination Market Size, 2018-2029
6.8.6 UAE Hepatitis A and B Vaccination Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Hepatitis A and B Vaccination Major Product Offerings
7.1.4 GSK Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Hepatitis A and B Vaccination Major Product Offerings
7.2.4 Merck Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Hepatitis A and B Vaccination Major Product Offerings
7.3.4 Sanofi Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Sinovac
7.4.1 Sinovac Company Summary
7.4.2 Sinovac Business Overview
7.4.3 Sinovac Hepatitis A and B Vaccination Major Product Offerings
7.4.4 Sinovac Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.4.5 Sinovac Key News & Latest Developments
7.5 Zhejiang Pukang
7.5.1 Zhejiang Pukang Company Summary
7.5.2 Zhejiang Pukang Business Overview
7.5.3 Zhejiang Pukang Hepatitis A and B Vaccination Major Product Offerings
7.5.4 Zhejiang Pukang Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.5.5 Zhejiang Pukang Key News & Latest Developments
7.6 Changchun Institute of Biological
7.6.1 Changchun Institute of Biological Company Summary
7.6.2 Changchun Institute of Biological Business Overview
7.6.3 Changchun Institute of Biological Hepatitis A and B Vaccination Major Product Offerings
7.6.4 Changchun Institute of Biological Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.6.5 Changchun Institute of Biological Key News & Latest Developments
7.7 KM Biologics
7.7.1 KM Biologics Company Summary
7.7.2 KM Biologics Business Overview
7.7.3 KM Biologics Hepatitis A and B Vaccination Major Product Offerings
7.7.4 KM Biologics Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.7.5 KM Biologics Key News & Latest Developments
7.8 IMBCAMS
7.8.1 IMBCAMS Company Summary
7.8.2 IMBCAMS Business Overview
7.8.3 IMBCAMS Hepatitis A and B Vaccination Major Product Offerings
7.8.4 IMBCAMS Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.8.5 IMBCAMS Key News & Latest Developments
7.9 Convac
7.9.1 Convac Company Summary
7.9.2 Convac Business Overview
7.9.3 Convac Hepatitis A and B Vaccination Major Product Offerings
7.9.4 Convac Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.9.5 Convac Key News & Latest Developments
7.10 NCPC
7.10.1 NCPC Company Summary
7.10.2 NCPC Business Overview
7.10.3 NCPC Hepatitis A and B Vaccination Major Product Offerings
7.10.4 NCPC Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.10.5 NCPC Key News & Latest Developments
7.11 Bio Kangtai
7.11.1 Bio Kangtai Company Summary
7.11.2 Bio Kangtai Hepatitis A and B Vaccination Business Overview
7.11.3 Bio Kangtai Hepatitis A and B Vaccination Major Product Offerings
7.11.4 Bio Kangtai Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.11.5 Bio Kangtai Key News & Latest Developments
7.12 Dynavax
7.12.1 Dynavax Company Summary
7.12.2 Dynavax Hepatitis A and B Vaccination Business Overview
7.12.3 Dynavax Hepatitis A and B Vaccination Major Product Offerings
7.12.4 Dynavax Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.12.5 Dynavax Key News & Latest Developments
7.13 Hissen
7.13.1 Hissen Company Summary
7.13.2 Hissen Hepatitis A and B Vaccination Business Overview
7.13.3 Hissen Hepatitis A and B Vaccination Major Product Offerings
7.13.4 Hissen Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.13.5 Hissen Key News & Latest Developments
7.14 LG Life Sciences
7.14.1 LG Life Sciences Company Summary
7.14.2 LG Life Sciences Business Overview
7.14.3 LG Life Sciences Hepatitis A and B Vaccination Major Product Offerings
7.14.4 LG Life Sciences Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.14.5 LG Life Sciences Key News & Latest Developments
7.15 Serum Institute
7.15.1 Serum Institute Company Summary
7.15.2 Serum Institute Business Overview
7.15.3 Serum Institute Hepatitis A and B Vaccination Major Product Offerings
7.15.4 Serum Institute Hepatitis A and B Vaccination Sales and Revenue in Global (2018-2023)
7.15.5 Serum Institute Key News & Latest Developments
8 Global Hepatitis A and B Vaccination Production Capacity, Analysis
8.1 Global Hepatitis A and B Vaccination Production Capacity, 2018-2029
8.2 Hepatitis A and B Vaccination Production Capacity of Key Manufacturers in Global Market
8.3 Global Hepatitis A and B Vaccination Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hepatitis A and B Vaccination Supply Chain Analysis
10.1 Hepatitis A and B Vaccination Industry Value Chain
10.2 Hepatitis A and B Vaccination Upstream Market
10.3 Hepatitis A and B Vaccination Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hepatitis A and B Vaccination Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Hepatitis A and B Vaccination in Global Market
Table 2. Top Hepatitis A and B Vaccination Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Hepatitis A and B Vaccination Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Hepatitis A and B Vaccination Revenue Share by Companies, 2018-2023
Table 5. Global Hepatitis A and B Vaccination Sales by Companies, (Units), 2018-2023
Table 6. Global Hepatitis A and B Vaccination Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Hepatitis A and B Vaccination Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Hepatitis A and B Vaccination Product Type
Table 9. List of Global Tier 1 Hepatitis A and B Vaccination Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis A and B Vaccination Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Hepatitis A and B Vaccination Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Hepatitis A and B Vaccination Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Hepatitis A and B Vaccination Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Hepatitis A and B Vaccination Sales (Units), 2018-2023
Table 15. By Type - Global Hepatitis A and B Vaccination Sales (Units), 2024-2029
Table 16. By Application – Global Hepatitis A and B Vaccination Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Hepatitis A and B Vaccination Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Hepatitis A and B Vaccination Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Hepatitis A and B Vaccination Sales (Units), 2018-2023
Table 20. By Application - Global Hepatitis A and B Vaccination Sales (Units), 2024-2029
Table 21. By Region – Global Hepatitis A and B Vaccination Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Hepatitis A and B Vaccination Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Hepatitis A and B Vaccination Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Hepatitis A and B Vaccination Sales (Units), 2018-2023
Table 25. By Region - Global Hepatitis A and B Vaccination Sales (Units), 2024-2029
Table 26. By Country - North America Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Hepatitis A and B Vaccination Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Hepatitis A and B Vaccination Sales, (Units), 2018-2023
Table 29. By Country - North America Hepatitis A and B Vaccination Sales, (Units), 2024-2029
Table 30. By Country - Europe Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Hepatitis A and B Vaccination Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Hepatitis A and B Vaccination Sales, (Units), 2018-2023
Table 33. By Country - Europe Hepatitis A and B Vaccination Sales, (Units), 2024-2029
Table 34. By Region - Asia Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Hepatitis A and B Vaccination Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Hepatitis A and B Vaccination Sales, (Units), 2018-2023
Table 37. By Region - Asia Hepatitis A and B Vaccination Sales, (Units), 2024-2029
Table 38. By Country - South America Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Hepatitis A and B Vaccination Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Hepatitis A and B Vaccination Sales, (Units), 2018-2023
Table 41. By Country - South America Hepatitis A and B Vaccination Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Hepatitis A and B Vaccination Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Hepatitis A and B Vaccination Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Hepatitis A and B Vaccination Sales, (Units), 2024-2029
Table 46. GSK Company Summary
Table 47. GSK Hepatitis A and B Vaccination Product Offerings
Table 48. GSK Hepatitis A and B Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. GSK Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Hepatitis A and B Vaccination Product Offerings
Table 52. Merck Hepatitis A and B Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Hepatitis A and B Vaccination Product Offerings
Table 56. Sanofi Hepatitis A and B Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Sinovac Company Summary
Table 59. Sinovac Hepatitis A and B Vaccination Product Offerings
Table 60. Sinovac Hepatitis A and B Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Sinovac Key News & Latest Developments
Table 62. Zhejiang Pukang Company Summary
Table 63. Zhejiang Pukang Hepatitis A and B Vaccination Product Offerings
Table 64. Zhejiang Pukang Hepatitis A and B Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Zhejiang Pukang Key News & Latest Developments
Table 66. Changchun Institute of Biological Company Summary
Table 67. Changchun Institute of Biological Hepatitis A and B Vaccination Product Offerings
Table 68. Changchun Institute of Biological Hepatitis A and B Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Changchun Institute of Biological Key News & Latest Developments
Table 70. KM Biologics Company Summary
Table 71. KM Biologics Hepatitis A and B Vaccination Product Offerings
Table 72. KM Biologics Hepatitis A and B Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. KM Biologics Key News & Latest Developments
Table 74. IMBCAMS Company Summary
Table 75. IMBCAMS Hepatitis A and B Vaccination Product Offerings
Table 76. IMBCAMS Hepatitis A and B Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. IMBCAMS Key News & Latest Developments
Table 78. Convac Company Summary
Table 79. Convac Hepatitis A and B Vaccination Product Offerings
Table 80. Convac Hepatitis A and B Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Convac Key News & Latest Developments
Table 82. NCPC Company Summary
Table 83. NCPC Hepatitis A and B Vaccination Product Offerings
Table 84. NCPC Hepatitis A and B Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. NCPC Key News & Latest Developments
Table 86. Bio Kangtai Company Summary
Table 87. Bio Kangtai Hepatitis A and B Vaccination Product Offerings
Table 88. Bio Kangtai Hepatitis A and B Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Bio Kangtai Key News & Latest Developments
Table 90. Dynavax Company Summary
Table 91. Dynavax Hepatitis A and B Vaccination Product Offerings
Table 92. Dynavax Hepatitis A and B Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Dynavax Key News & Latest Developments
Table 94. Hissen Company Summary
Table 95. Hissen Hepatitis A and B Vaccination Product Offerings
Table 96. Hissen Hepatitis A and B Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Hissen Key News & Latest Developments
Table 98. LG Life Sciences Company Summary
Table 99. LG Life Sciences Hepatitis A and B Vaccination Product Offerings
Table 100. LG Life Sciences Hepatitis A and B Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. LG Life Sciences Key News & Latest Developments
Table 102. Serum Institute Company Summary
Table 103. Serum Institute Hepatitis A and B Vaccination Product Offerings
Table 104. Serum Institute Hepatitis A and B Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Serum Institute Key News & Latest Developments
Table 106. Hepatitis A and B Vaccination Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 107. Global Hepatitis A and B Vaccination Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Hepatitis A and B Vaccination Production by Region, 2018-2023 (Units)
Table 109. Global Hepatitis A and B Vaccination Production by Region, 2024-2029 (Units)
Table 110. Hepatitis A and B Vaccination Market Opportunities & Trends in Global Market
Table 111. Hepatitis A and B Vaccination Market Drivers in Global Market
Table 112. Hepatitis A and B Vaccination Market Restraints in Global Market
Table 113. Hepatitis A and B Vaccination Raw Materials
Table 114. Hepatitis A and B Vaccination Raw Materials Suppliers in Global Market
Table 115. Typical Hepatitis A and B Vaccination Downstream
Table 116. Hepatitis A and B Vaccination Downstream Clients in Global Market
Table 117. Hepatitis A and B Vaccination Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hepatitis A and B Vaccination Segment by Type in 2022
Figure 2. Hepatitis A and B Vaccination Segment by Application in 2022
Figure 3. Global Hepatitis A and B Vaccination Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hepatitis A and B Vaccination Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Hepatitis A and B Vaccination Revenue, 2018-2029 (US$, Mn)
Figure 7. Hepatitis A and B Vaccination Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Hepatitis A and B Vaccination Revenue in 2022
Figure 9. By Type - Global Hepatitis A and B Vaccination Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Hepatitis A and B Vaccination Revenue Market Share, 2018-2029
Figure 11. By Type - Global Hepatitis A and B Vaccination Sales Market Share, 2018-2029
Figure 12. By Type - Global Hepatitis A and B Vaccination Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Hepatitis A and B Vaccination Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Hepatitis A and B Vaccination Revenue Market Share, 2018-2029
Figure 15. By Application - Global Hepatitis A and B Vaccination Sales Market Share, 2018-2029
Figure 16. By Application - Global Hepatitis A and B Vaccination Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Hepatitis A and B Vaccination Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Hepatitis A and B Vaccination Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Hepatitis A and B Vaccination Revenue Market Share, 2018-2029
Figure 20. By Region - Global Hepatitis A and B Vaccination Sales Market Share, 2018-2029
Figure 21. By Country - North America Hepatitis A and B Vaccination Revenue Market Share, 2018-2029
Figure 22. By Country - North America Hepatitis A and B Vaccination Sales Market Share, 2018-2029
Figure 23. US Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Hepatitis A and B Vaccination Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Hepatitis A and B Vaccination Sales Market Share, 2018-2029
Figure 28. Germany Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2029
Figure 29. France Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Hepatitis A and B Vaccination Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Hepatitis A and B Vaccination Sales Market Share, 2018-2029
Figure 37. China Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2029
Figure 41. India Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Hepatitis A and B Vaccination Revenue Market Share, 2018-2029
Figure 43. By Country - South America Hepatitis A and B Vaccination Sales Market Share, 2018-2029
Figure 44. Brazil Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Hepatitis A and B Vaccination Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Hepatitis A and B Vaccination Sales Market Share, 2018-2029
Figure 48. Turkey Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Hepatitis A and B Vaccination Revenue, (US$, Mn), 2018-2029
Figure 52. Global Hepatitis A and B Vaccination Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Hepatitis A and B Vaccination by Region, 2022 VS 2029
Figure 54. Hepatitis A and B Vaccination Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ A型肝炎＆B型肝炎予防接種の世界市場見通し2023年-2029年(Hepatitis A and B Vaccination Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

A型肝炎＆B型肝炎予防接種の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp